SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-06-053476
Filing Date
2006-12-19
Accepted
2006-12-19 17:24:46
Documents
3
Period of Report
2006-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v060818.txt 8-K 6428
2 v060818_ex10-1.txt EX-10.1 13826
3 v060818_ex10-2.txt EX-10.2 27449
  Complete submission text file 0001144204-06-053476.txt   49599
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-61610 | Film No.: 061287448
SIC: 2836 Biological Products, (No Diagnostic Substances)